Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC)
Conditions
- Non-small Cell Lung Cancer
Interventions
- DRUG: recombinant human endostatin
Sponsor
Shanghai Jiao Tong University School of Medicine
Collaborators
- [object Object]
- [object Object]
- [object Object]